High nasopharyngeal carriage of non-vaccine serotypes in western australian aboriginal people following 10 years of pneumococcal conjugate vaccination

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Collins, Deirdre A ^a   Hoskins, Anke ^a   Bowman, Jacinta ^b   Jones, Jade ^b   Stemberger, Natalie A ^b,c   Richmond, Peter C ^c   Leach, Amanda J ^d   Lehmann, Deborah ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b PATHWEST LABORATORY MEDICINE   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^d MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTRIAXONE; CHLORAMPHENICOL; COTRIMOXAZOLE; ERYTHROMYCIN; PENICILLIN DERIVATIVE; PNEUMOCOCCUS VACCINE; TETRACYCLINE;

ABORIGINE; ADOLESCENT; ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; AUSTRALIA; BACTERIUM CARRIER; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BIOLOGICAL MONITORING; CHILD; CULTURE MEDIUM; EPIDEMIC; FEMALE; HAEMOPHILUS INFLUENZAE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MINIMUM INHIBITORY CONCENTRATION; MORAXELLA CATARRHALIS; MULTIDRUG RESISTANCE; NASOPHARYNX; NONHUMAN; PENICILLIN RESISTANCE; PNEUMOCOCCAL INFECTION; PRESCHOOL CHILD; PREVENTIVE HEALTH SERVICE; SCHOOL CHILD; SEROTYPE; STREPTOCOCCUS PNEUMONIAE; VACCINATION; YOUNG ADULT;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANTI-INFECTIVE AGENTS; CARRIER STATE; CHILD; CHILD, PRESCHOOL; FEMALE; GEOGRAPHY; HUMANS; INFANT; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; NASOPHARYNX; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; POPULATION GROUPS; PREVALENCE; SEROTYPING; STREPTOCOCCUS PNEUMONIAE; VACCINATION; VACCINES, CONJUGATE; WESTERN AUSTRALIA;

EID: 84891592897     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0082280     Document Type: Article

References (30)

1. World Health Organization (2012) Pneumococcal vaccines WHO position paper - 2012. Weekly Epidemiological Record 87: 129-144.
2. Lehmann D, Willis J, Moore HC, Giele C, Murphy D et al. (2010) The changing epidemiology of invasive pneumococcal disease in Aboriginal and non-Aboriginal Western Australians from 1997 through 2007 and emergence of nonvaccine serotypes. Clin Infect Dis 50: 1477-1486. doi: 10.1086/652440. PubMed: 20420501.
3. Lehmann D, Weeks S, Jacoby P, Elsbury D, Finucane J et al. (2008) Absent otoacoustic emissions predict otitis media in young Aboriginal children: A birth cohort study in Aboriginal and non-Aboriginal children in an arid zone of Western Australia. BMC Pediatr 8: 32. doi:10.1186/1471-2431-8-32. PubMed: 18755038.
4. Jacoby P, Carville KS, Hall G, Riley TV, Bowman J et al. (2011) Crowding and other strong predictors of upper respiratory tract carriage of otitis media-related bacteria in Australian Aboriginal and non-Aboriginal children. Pediatr Infect Dis J 30: 480-485. PubMed: 21593705.
5. th International Symposium on Pneumococci and Pneumococcal Diseases, Iguacu Falls, Brazil.
6. Weinberger DM, Harboe ZB, Flasche S, Scott JA, Lipsitch M (2011) Prediction of serotypes causing invasive pneumococcal disease in unvaccinated and vaccinated populations. Epidemiology 22: 199-207. doi:10.1097/01.ede. 0000392293.11358.8c. PubMed: 21646962.
7. Tocheva AS, Jefferies JMC, Rubery H, Bennett J, Afimeke G et al. (2011) Declining serotype coverage of new pneumococcal conjugate vaccines relating to the carriage of Streptococcus pneumoniae in young children. Vaccine 29: 4400-4404. doi:10.1016/j.vaccine.2011.04.004. PubMed: 21504773.
8. Spijkerman J, van Gils EJ, Veenhoven RH, Hak E, Yzerman EP et al. (2011) Carriage of Streptococcus pneumoniae 3 years after start of vaccination program, the Netherlands. Emerg Infect Dis 17: 584-591. doi:10.3201/eid1704101115. PubMed: 21470445.
9. Leach AJ, Morris PS, McCallum GB, Wilson CA, Stubbs L et al. (2009) Emerging pneumococcal carriage serotypes in a high-risk population receiving universal 7-valent pneumococcal conjugate vaccine and 23-valent polysaccharide vaccine since 2001. BMC Infect Dis 9: 121. doi: 10.1186/1471-2334-9-121. PubMed: 19650933.
10. Australian Bureau of Statistics (2011) 2011 Census of Population and Housing. Canberra
11. Leach AJ, Stubbs E, Hare K, Beissbarth J, Morris PS (2008) Comparison of nasal swabs with nose blowing for community-based pneumococcal surveillance of healthy children. J Clin Microbiol 46: 2081-2082. doi:10.1128/JCM.00048-08. PubMed: 18385438.
12. Watson K, Carville K, Bowman J, Jacoby P, Riley TV et al. (2006) Upper respiratory tract bacterial carriage in Aboriginal and non-Aboriginal children in a semi-arid area of Western Australia. Pediatr Infect Dis J 25: 782-790. doi:10.1097/01.inf.0000232705.49634.68. PubMed: 16940834.
13. Clinical and Laboratory Standards Institute (2007) Performance Standards for Antimicrobial Susceptibility Testing: Seventh Informational Supplement M100-S17. Wayne, PA, USA: CLSI.
14. Pai R, Moore MR, Pilishvili T, Gertz RE, Whitney CG et al. (2005) Postvaccine genetic structure of Streptococcus pneumoniae serotype 19A from children in the United States. J Infect Dis 192: 1988-1995. doi:10.1086/498043. PubMed: 16267772.
15. Mackenzie GA, Leach AJ, Carapetis JR, Fisher J, Morris PS (2010) Epidemiology of nasopharyngeal carriage of respiratory bacterial pathogens in children and adults: cross-sectional surveys in a population with high rates of pneumococcal disease. BMC Infect Dis 10: 304. doi:10.1186/1471-2334-10-304. PubMed: 20969800.
16. Abdullahi O, Karani A, Tigoi CC, Mugo D, Kungu S et al. (2012) The prevalence and risk factors for pneumococcal colonization of the nasopharynx among children in Kilifi district, Kenya. PLOS ONE 7: e30787. doi:10.1371/journal.pone.0030787. PubMed: 22363489.
17. Roca A, Bottomley C, Hill PC, Bojang A, Egere U et al. (2012) Effect of age and vaccination with a pneumococcal conjugate vaccine on the density of pneumococcal nasopharyngeal carriage. Clin Infect Dis 55: 816-824. doi:10.1093/cid/cis554. PubMed: 22700830.
18. Rivera-Olivero IA, Bogaert D, Bello T, del Nogal B, Sluijter M et al. (2007) Pneumococcal carriage among indigenous Warao children in Venezuela: serotypes, susceptibility patterns, and molecular epidemiology. Clin Infect Dis 45: 1427-1434. doi:10.1086/522984. PubMed: 17990224.
19. Rudolph K, Bruce M, Bruden D, Zulz T, Wenger J et al. (2013) Epidemiology of pneumococcal serotype 6A and 6C among invasive and carriage isolates from Alaska, 1986-2009. Diagn Microbiol Infect Dis 75: 271-276. doi:10.1016/j. diagmicrobio.2012.11.021. PubMed: 23276772.
20. Park IH, Moore MR, Treanor JJ, Pelton SI, Pilishvili T et al. (2008) Differential effects of pneumococcal vaccines against serotypes 6A and 6C. J Infect Dis 198: 1818-1822. doi:10.1086/593339. PubMed: 18983249.
21. Väkeväinen M, Eklund C, Eskola J, Käyhty H (2001) Cross-reactivity of antibodies to type 6B and 6A polysaccharides of Streptococcus pneumoniae, evoked by pneumococcal conjugate vaccines, in infants. J Infect Dis 184: 789-793. doi:10.1086/322984. PubMed: 11517443.
22. Cooper D, Yu X, Sidhu M, Nahm MH, Fernsten P et al. (2011) The 13-valent pneumococcal conjugate vaccine (PCV13) elicits cross-functional opsonophagocytic killing responses in humans to Streptococcus pneumoniae serotypes 6C and 7A. Vaccine 29: 7207-7211. doi:10.1016/j.vaccine.2011.06.056. PubMed: 21689707.
23. Marsh RL, Smith-Vaughan H, Beissbarth J, Hare K, Kennedy M et al. (2007) Molecular characterisation of pneumococcal serotype 16F: Established predominant carriage and otitis media serotype in the 7vPCV era. Vaccine 25: 2434-2436. doi:10.1016/j.vaccine.2006.09.016. PubMed: 17028080.
24. Menzies R, Turnour C, Chiu C, McIntyre P (2008) Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia 2003 to 2006. Communicable Diseases Intelligence 32: S2-67. PubMed: 18711998.
25. Simell B, Auranen K, Käyhty H, Goldblatt D, Dagan R et al. (2012) The fundamental link between pneumococcal carriage and disease. Expert Rev Vaccines 11: 841-855. doi:10.1586/erv.12.53. PubMed: 22913260.
26. Brueggemann AB, Griffiths DT, Meats E, Peto T, Crook DW et al. (2003) Clonal relationships between invasive and carriage Streptococcus pneumoniae and serotype- and clone-specific differences in invasive disease potential. J Infect Dis 187: 1424-1432. doi:10.1086/374624. PubMed: 12717624.
27. Scott JR, Millar EV, Lipsitch M, Moulton LH, Weatherholtz R et al. (2012) Impact of more than a decade of pneumococcal conjugate vaccine use on carriage and invasive potential in Native American communities. J Infect Dis 205: 280-288. doi:10.1093/infdis/jir730.PubMed: 22128315.
28. Wiertsema SP, Kirkham LA, Corscadden KJ, Mowe EN, Bowman JM et al. (2011) Predominance of nontypeable Haemophilus influenzae in children with otitis media following introduction of a 3+0 pneumococcal conjugate vaccine schedule. Vaccine 29: 5163-5170. doi:10.1016/j.vaccine.2011.05.035. PubMed: 21621576.
29. Lehmann D, Arumugaswamy A, Elsbury D, Finucane J, Stokes A et al. (2008) The Kalgoorlie Otitis Media Research Project: rationale, methods, population characteristics and ethical considerations. Paediatr Perinat Epidemiol 22: 60-71. PubMed: 18173785.
30. Weinberger DM, Malley R, Lipsitch M (2011) Serotype replacement in disease after pneumococcal vaccination. Lancet 378: 1962-1973. doi: 10.1016/S0140-6736(10)62225-8. PubMed: 21492929.